Last reviewed: June 15, 2026
Last updated: June 15, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists represent a major advancement in weight management, with delivery methods ranging from weekly injections to daily oral tablets. PlexusDx offers multiple administration pathways, all sourced from licensed 503A compounding pharmacies, allowing patients to select the format that best fits their routine and treatment objectives.
Injectable GLP-1 Medications: How Weekly Injections Work
GLP-1 injection therapy delivers medication directly into subcutaneous tissue—the layer beneath your skin—where it absorbs gradually over seven days. This sustained-release profile means you inject once weekly, typically on the same day each week, making adherence straightforward for most patients. The injection site may be rotated between the abdomen, thigh, or upper arm to minimize tissue irritation and optimize absorption consistency.
Compounded semaglutide injection from PlexusDx starts at $149 per month and uses a thin, short needle that most patients find minimally uncomfortable. The standard protocol involves a starting dose that increases gradually every four weeks, allowing your body to adjust while you experience progressive appetite suppression. Your dose may need to go up. Your price won't—all doses remain the same monthly flat rate across PlexusDx commitment tiers.
Weekly injection schedules offer several practical advantages: they reduce daily medication burden, require only four administrations monthly, and allow flexibility in dosing adjustments based on your response. Many patients report that the predictable weekly rhythm becomes habitual within the first month, reducing the cognitive load of managing their treatment.
Oral GLP-1 Tablets: Daily Administration and Absorption
Oral semaglutide tablets bypass injection altogether, requiring a simple daily swallowing routine that integrates easily into morning or evening medication schedules. Unlike injectable semaglutide, which is absorbed through subcutaneous tissue, oral formulations must navigate the digestive system while maintaining bioavailability—the percentage of the drug that reaches your bloodstream in active form. Proper administration timing and food state matter significantly with oral GLP-1 medications to ensure consistent absorption.
PlexusDx oral semaglutide starts at $249 per month and is taken once daily on an empty stomach, typically 30 minutes before breakfast. The once-daily format appeals to patients who prefer avoiding injections or have needle anxiety, though it requires daily compliance and careful attention to administration guidelines. Like all PlexusDx options, oral semaglutide pricing remains flat regardless of dose escalation, providing cost predictability throughout your treatment journey.
Oral formulations may show slightly slower onset compared to injections, with therapeutic effects building over two to three weeks as your system adapts to daily dosing. Gastrointestinal side effects sometimes occur with oral GLP-1 tablets, particularly during dose adjustments, though most symptoms resolve as your tolerance increases.
Dual-Compound GLP-Squared: Combination Injection and Oral Options
PlexusDx GLP-Squared represents a breakthrough approach combining semaglutide and tirzepatide in a single formulation, targeting multiple metabolic pathways simultaneously. This dual-compound strategy activates both GLP-1 and GIP (glucose-dependent insulinotropic peptide) receptors, which may enhance weight loss and metabolic improvements compared to single-agent therapy. GLP-Squared injection starts at $249 per month, while the oral version begins at $369 per month.
Patients considering GLP-Squared benefit from the Precision Peptide Genetic Test ($99 add-on after the first month), which analyzes 14 metabolic pathways and identifies how your genetics influence peptide responsiveness. Key variants like GIPR rs1800437 and GLP1R rs6923761 help predict which dual-compound format may yield superior results for your individual biology, personalizing your GLP-1 administration strategy beyond standard one-size-fits-all dosing.
Both injection and oral GLP-Squared formulations maintain the same flat monthly pricing regardless of dose level, allowing seamless upgrades as your treatment deepens without budget surprises. The combination approach proves particularly effective for patients with moderate to severe obesity or metabolic resistance to single-agent GLP-1 therapy.
Microdose GLP-1 Protocol: Low-Dose Entry Point for Sensitive Patients
The Microdose GLP-1 Protocol at $129 per month offers an entry pathway for patients who experience significant gastrointestinal sensitivity or prefer a gradual metabolic introduction. This ultra-low-dose format delivers therapeutic GLP-1 activity while minimizing nausea, vomiting, and appetite suppression intensity during the critical early weeks of treatment. Microdose protocols work particularly well for patients new to GLP-1 therapy or those transitioning from other weight management medications.
Administration follows the same weekly injection schedule as standard semaglutide, ensuring consistency in your routine while your body builds tolerance to the medication's effects. Many patients begin with the Microdose protocol for four to eight weeks, then transition to standard semaglutide or tirzepatide dosing as gastrointestinal adaptation occurs. This phased approach reduces dropout rates from side effects and improves long-term treatment success.
Because the Microdose Protocol costs $129 monthly—PlexusDx's most affordable entry point—patients can trial GLP-1 therapy with minimal financial commitment while determining whether injectable versus oral formats suit their lifestyle best.
Choosing Your Administration Method: Key Decision Factors
Selecting between injection and oral GLP-1 administration depends on personal preference, lifestyle compatibility, and medical history. Injection therapy suits patients who value weekly convenience, prefer avoiding daily pill compliance, and tolerate needles well. Oral tablets appeal to those with needle phobia, those seeking daily medication ritual consistency, or those interested in simplified prescription refill patterns.
PlexusDx serves all 50 states with no insurance requirement, no membership fees, and HSA/FSA eligibility across all administration formats. Your choice of injection versus oral versus dual-compound doesn't affect pricing tier placement—all commitment levels maintain flat monthly rates, ensuring your administration decision rests purely on medical and lifestyle fit rather than cost consideration.
Consulting with PlexusDx providers about your metabolism, job demands, injection comfort level, and gastrointestinal baseline helps match you with the administration method maximizing adherence and treatment outcomes. The Precision Peptide Genetic Test further refines this decision by revealing your individual peptide-pathway responsiveness, enabling data-driven administration selection.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How often do I need to inject semaglutide if I choose the injection route?
Semaglutide injection is administered once weekly, typically on the same day each week for maximum consistency. You rotate injection sites between your abdomen, thigh, and upper arm to maintain comfortable tissue health. PlexusDx compounded semaglutide injection starts at $149 per month regardless of which dose week you're on.
What's the difference between injectable and oral GLP-1 administration at the cellular level?
Injectable semaglutide deposits medication in subcutaneous tissue for gradual seven-day absorption, while oral tablets must survive stomach acid and intestinal processing to reach systemic circulation. Oral formulations require administration on an empty stomach to optimize bioavailability, whereas injections bypass digestive variability entirely. Both methods eventually activate GLP-1 receptors throughout your body, but their absorption kinetics differ significantly.
Does PlexusDx charge different prices based on administration method or dose level?
No. PlexusDx pricing is flat per medication regardless of dose escalation or administration frequency. Compounded semaglutide injection starts at $149 monthly, oral semaglutide at $249, and tirzepatide options at $249-$279—with all doses covered under the same monthly price. Your dose may need to go up. Your price won't.
Are there safety differences between injection and oral GLP-1 administration?
Both delivery methods are safe when sourced from licensed 503A compounding pharmacies, as PlexusDx provides. Injectable routes avoid first-pass liver metabolism and gastrointestinal variability, potentially reducing nausea in some patients. Oral administration risks more gastrointestinal side effects during dose transitions but offers simplicity and no injection site reactions. Your PlexusDx provider helps assess which method suits your safety profile.
How does the Precision Peptide Genetic Test help me choose between injection and oral administration?
The Precision Peptide Genetic Test ($99 add-on) analyzes 14 metabolic pathways and 150+ genetic insights, including GLP1R rs6923761 variants that predict your GLP-1 receptor sensitivity. Patients with certain genetic profiles may show superior response to injectable formats that bypass digestive variability, while others respond equally well to oral tablets. This personalization ensures your administration choice aligns with your genetics, not just preference.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Do GLP-1 Supplements Actually Work? Separating Fact from Fiction
Glutathione and Ozempic Together — What You Need to Know